1.52
-0.03(-1.94%)
Currency In USD
| Previous Close | 1.55 |
| Open | 1.6 |
| Day High | 1.72 |
| Day Low | 1.51 |
| 52-Week High | 7.95 |
| 52-Week Low | 1.42 |
| Volume | 176,761 |
| Average Volume | 133,155 |
| Market Cap | 8.95M |
| PE | -0.86 |
| EPS | -1.77 |
| Moving Average 50 Days | 1.94 |
| Moving Average 200 Days | 3.06 |
| Change | -0.03 |
If you invested $1000 in Vivos Therapeutics, Inc. (VVOS) since IPO date, it would be worth $6.76 as of February 14, 2026 at a share price of $1.52. Whereas If you bought $1000 worth of Vivos Therapeutics, Inc. (VVOS) shares 5 years ago, it would be worth $7.97 as of February 14, 2026 at a share price of $1.52.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
GlobeNewswire Inc.
Feb 05, 2026 1:45 PM GMT
Vivos adds more cutting-edge products to its roster serving the breathing and sleep wellness market LITTLETON, Colo., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device an
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
GlobeNewswire Inc.
Jan 20, 2026 10:31 PM GMT
LITTLETON, Colo., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on sleep related breathing disorders, including obstructive
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
GlobeNewswire Inc.
Jan 16, 2026 1:00 PM GMT
LITTLETON, Colo., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on sleep related breathing disorders, including obstructive sl